1. Zegui Ni#, Pengli Sun#, Jin Zheng#, Mingqing Wu#, Congcong Yang, Maosheng Cheng, Mingwei Yin, Chengying Cui, Guangxian Wang, Lin Yuan, Qian Gao*, and Yang Li*. JNK signaling promotes bladder cancer immune escape by regulating METTL3-mediated m6A modification of PD-L1 mRNA. Cancer Research.2022
2. Gao Q, Zheng J, Ni Z, Sun P, Yang C, Cheng M, Wu M, Zhang X, Yuan L, Zhang Y, Li Y. The m(6)A Methylation-Regulated AFF4 Promotes Self-Renewal of Bladder Cancer Stem Cells. Stem cells international. 2020;2020:8849218.
3. Wu M#, Sheng L#, Cheng M, Zhang H, Jiang Y, Lin S, Liang Y, Zhu F, Liu Z, Zhang Y, Zhang X, Gao Q, Chen D*, Li J*, Li Y*. Low doses of decitabine improve the chemotherapy efficacy against basal-like bladder cancer by targeting cancer stem cells. Oncogene. 2019;38:5425-39.
4. Cheng M#, Sheng L#, Gao Q#, Xiong Q, Zhang H, Wu M, Liang Y, Zhu F, Zhang Y, Zhang X, Yuan Q, Li Y*. The m(6)A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-kappaB/MYC signaling network. Oncogene. 2019;38:3667-80.
5. Zhu FY#, Qian WQ#, Zhang HJ#, Liang Y, Wu MQ, Zhang YY, Zhang XH, Gao Q, Li Y*. SOX2 Is a Marker for Stem-like Tumor Cells in Bladder Cancer. Stem Cell Rep. 2017;9:429-37.